BSE See NSE See 37,363.43
809.83 (2.22%)

DSIJ Mindshare

Cipla gets final nod for generic therapeutic equivalent of Tecfidera; stock opens 1.52 per cent higher

rishikesh gaikwad / Article rating: 3.9

Cipla Limited today announced that it has received final approval for its abbreviated new drug application (ANDA) for Dimethyl Fumarate DR Capsules 120mg, 240mg, and 120mg/240mg starter pack from United States Food & Drug Administration (USFDA).

Tata Elxsi opens Global Engineering Centre with Schaeffler Technologies

rishikesh gaikwad / Article rating: 3.6

Tata Elxsi, a global design and technology services company, announced the opening of a Global Engineering Centre (GEC) with Schaeffler Technologies AG & Co. KG, a world leader in providing mechatronics solutions for the transportation industry. Schaeffler Group is a global supplier to the automotive and industrial sectors.

Phoenix Group partners with TCS

rishikesh gaikwad / Article rating: 3.6

Tata Consultancy Services (TCS) announced that it has partnered with Phoenix Group, the UK’s largest long-term savings and retirement business, to launch an enhanced client analytics tool for workplace pension clients of its Standard Life Assurance Limited business.

ICICI Prudential Life Insurance partners with NSDL Payments Bank; stock up by 2.95 per cent

rishikesh gaikwad / Article rating: 3.7

ICICI Prudential Life Insurance informed today that it has entered into a corporate agency agreement with NSDL Payments Bank, a subsidiary of NSDL, the largest depository of India. Post this announcement, the stock of ICICI Prudential Life Insurance was seen trading at Rs 447.20, up by 2.95 per cent at 12.44 pm. 

Dr Reddy’s Laboratories announces launch of 2 separate products in Indian & US market

rishikesh gaikwad / Article rating: 4.3

Dr Reddy’s Laboratories Ltd announced the launch of Remdesivir along with its subsidiaries on Wednesday. The product is being launched under the brand name of Redyx in India. Additionally, it also announced the launch of over-the-counter (OTC) Diclofenac Sodium Topical Gel 1 per cent, the store brand version of Voltaren® Arthritis Pain in the US market.